# A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers

> **NCT00797342** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 27 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PF-04629991
- **DRUG:** PF-04629991
- **DRUG:** PF-04629991

## Key facts

- **NCT ID:** NCT00797342
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2009-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00797342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00797342, "A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04629991 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00797342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*